Choosing drugs for UK COVID-19 treatment trials. (2022)

First Author: Chinnery PF
Attributed to:  Mechanisms of oxygen toxicity in the context of mitochondrial dysfunction funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/d41573-021-00203-7

PubMed Identifier: 34876668

Publication URI: http://europepmc.org/abstract/MED/34876668

Type: Journal Article/Review

Volume: 21

Parent Publication: Nature reviews. Drug discovery

Issue: 2

ISSN: 1474-1776